Market Research Logo

Depression Therapeutics Market, by Drug Type, Distribution Channel, and Region - Global Trends, and Forecast till 2025

Depression Therapeutics Market, by Drug Type, Distribution Channel, and Region - Global Trends, and Forecast till 2025

Antidepressants are prescribed in serious to mild mental health conditions such as major depression and anxiety. Antidepressant drug category is highly lucrative due to low availability of alternative drug therapies for treatment of such disorders. Drug manufacturers are increasingly advancing the antidepressant drug category by introducing innovative therapies such as selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs). Depression is one of the most common mental disorders, which are primarily treated by antidepressants. According to National Health Service Digital (NHS Digital), UK, antidepressant medication prescriptions observed the largest increase in 2016.
Market Dynamics
The global depression therapeutics market is driven by factors such as absence of alternative therapies and high presence of generic drug manufacturers in the market. Increasing number of major drugs are losing patent protection due to which increasing number of generic manufacturers are developing product variations, this in turn is boosting the growth of the market. Proven effectiveness of these medications in improving medical outcomes and increasing prevalence of disorders such as depression are fueling growth of the market. However, life threatening side effects associated with these medications as indicated by the black box warning on the packaging, as well as lack of research and development by major players are expected to hinder growth of the depression therapeutics market.
Key features of the study:

This report provides in-depth analysis of the global depression therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global depression therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, AstraZeneca Plc, Allergan Plc, GlaxoSmithKline Plc, Intellipharmaceutics International, Inc., Takeda Pharmaceutical Company Limited, H.Lundbeck A/S, Otsuka Holdings Co.,Ltd., Apotex, Inc., Shionogi & Co. Ltd., Zhejiang Hua Hai Pharmaceutical Co., Ltd, and Chengdu Kanghong Pharmaceutical Group Co.,Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global depression therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global depression therapeutics market

Detailed Segmentation:

Global Depression Therapeutics Market, By Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others

Global Depression Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Global Depression Therapeutics Market, By Geography:

North America

By Drug Type

Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Country:

U.S.
Canada
Mexico

Europe

By Drug Type

Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Drug Type

Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Country:

China
India
Japan
Southeast Asia
Australia
South Korea
Rest of Asia Pacific

South America

By Drug Type

Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Country:

Brazil
Argentina
Colombia
Rest of South America

Middle East & Africa

By Drug Type

Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Country:

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of Middle East & Africa

Company Profiles

Pfizer, Inc.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Eily Lilly, and Company
AstraZeneca Plc
Allergan Plc
GlaxoSmithKline Plc
Intellipharmaceutics International, Inc.
Takeda Pharmaceutical Company Limited
Lundbeck A/S
Otsuka Holdings Co. Ltd.
Apotex, Inc.
Shionogi & Co. Ltd.
Zhejiang Hua Hai Pharmaceutical Co., Ltd
Chengdu Kanghong Pharmaceutical Group Co. Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
PEST Analysis
PORTER’s Five Forces Analysis
Pipeline Analysis
4. Global Depression Therapeutics Market, By Drug Type, 2017–2025, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Selective Serotonin Reuptake Inhibitors (SSRIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
5. Global Depression Therapeutics Market, By Distribution Channel, 2017–2025, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
6. Global Depression Therapeutics Market, By Regions, 2017–2025, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2025
North America
Market Size and Forecast, By Drug Type, 2017–2025, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017–2025, (US$ Mn)
Market Size and Forecast, By Country, 2017–2025, (US$ Mn)
U.S.
Canada
Mexico
Europe
Market Size and Forecast, By Drug Type, 2017–2025, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017–2025, (US$ Mn)
Market Size and Forecast, By Country, 2017–2025, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2017–2025, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017–2025, (US$ Mn)
Market Size and Forecast, By Country, 2017–2025, (US$ Mn)
China
India
Japan
Southeast Asia
Australia
South Korea
Rest of Asia Pacific
South America
Market Size and Forecast, By Drug Type, 2017–2025, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017–2025, (US$ Mn)
Market Size and Forecast, By Country, 2017–2025, (US$ Mn)
Brazil
Argentina
Colombia
Rest of South America
Middle East & Africa
Market Size and Forecast, By Drug Type, 2017–2025, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of Middle East & Africa
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Eily, Lilly, and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca, Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Allergan Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Intellipharmaceutics International, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Takeda Pharmaceutical Company Limited
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
H.Lundbeck A/S
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Otsuka Holdings Co. Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Apotex, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Shionogi & Co. Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Zhejiang Hua Hai Pharmaceutical Co., Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Chengdu Kanghong Pharmaceutical Group Co. Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About Us and Sales Contact
*Browse 34 market data tables and 73 figures on "Depression Therapeutics Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report